WIENS HAROLD J 4
4 · BIO-TECHNE Corp · Filed May 4, 2020
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
WIENS HAROLD J
Director
Transactions
- Exercise/Conversion
Common Stock
2020-04-30$91.78/sh+4,000$367,120→ 9,221 total - Sale
Common Stock
2020-04-30$225.00/sh−4,000$900,000→ 5,221 total - Exercise/Conversion
Stock Option (right to buy)
2020-04-30−4,000→ 0 totalExercise: $91.78From: 2014-10-30Exp: 2024-10-30→ Common Stock (4,000 underlying)
Holdings
- 4,260
Stock Option (right to buy)
Exercise: $87.34From: 2016-10-29Exp: 2025-10-28→ Common Stock (4,260 underlying) - 3,125
Stock Option (right to buy)
Exercise: $125.05From: 2018-10-25Exp: 2027-10-26→ Common Stock (3,125 underlying) - 3,985
Stock Option (right to buy)
Exercise: $101.19From: 2017-10-26Exp: 2026-10-26→ Common Stock (3,985 underlying) - 1,898
Stock Option (right to buy)
Exercise: $179.84From: 2019-10-24Exp: 2028-10-25→ Common Stock (1,898 underlying) - 2,011
Stock Option (right to buy)
Exercise: $201.64Exp: 2029-10-24→ Common Stock (2,011 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 31, 2019.
- [F2]The option vests on the earlier of the one year anniversary of the grant date (10/24/2019) or the date of Bio-Techne's 2020 annual meeting of shareholders.